4//SEC Filing
McDevitt Damien 4
Accession 0001209191-20-054613
CIK 0001662524other
Filed
Oct 12, 8:00 PM ET
Accepted
Oct 13, 3:54 PM ET
Size
9.9 KB
Accession
0001209191-20-054613
Insider Transaction Report
Form 4
McDevitt Damien
Director
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2020-10-12$5.39/sh−120,000$646,800→ 0 totalExercise: $12.76Exp: 2030-03-18→ Common Stock (120,000 underlying) - Disposition from Tender
Common Stock
2020-10-12$18.15/sh−242,978$4,410,051→ 0 total - Disposition to Issuer
Stock Option (right to buy)
2020-10-12$5.39/sh−200,000$1,078,000→ 0 totalExercise: $12.76Exp: 2030-03-18→ Common Stock (200,000 underlying)
Footnotes (2)
- [F1]This option, which provided that 1/4th of the shares would vest one year after March 19, 2020 and 1/48th of the shares would vest monthly thereafter over the next three years, was cancelled in connection with the merger of the Issuer with a wholly owned subsidiary of Ionis Pharmaceuticals, Inc. in exchange for a cash payment of $646,800.00, representing the difference between the exercise price of the option and the acquisition price of $18.15.
- [F2]This option, which provided that 1/4th of the shares would vest one year after March 19, 2020 and 1/48th of the shares would vest monthly thereafter over the next three years, was cancelled in connection with the merger of the Issuer with a wholly owned subsidiary of Ionis Pharmaceuticals, Inc. in exchange for a cash payment of $1,078,000.00, representing the difference between the exercise price of the option and the acquisition price of $18.15.
Documents
Issuer
AKCEA THERAPEUTICS, INC.
CIK 0001662524
Entity typeother
Related Parties
1- filerCIK 0001742277
Filing Metadata
- Form type
- 4
- Filed
- Oct 12, 8:00 PM ET
- Accepted
- Oct 13, 3:54 PM ET
- Size
- 9.9 KB